Specifically, these mechanisms include upregulating the expression of tumor antigens, enhancing antigen-processing ability, improving the cytolytic activity of CD8+ T cells, and disrupting the immunosuppressive function of IL-10 producing regulatory T cells (26–29). This evidence concerns the gene CD8A and neoplasm.